Bioactive luminescent transition-metal complexes for biomedical applications. 2013

Dik-Lung Ma, and Hong-Zhang He, and Ka-Ho Leung, and Daniel Shiu-Hin Chan, and Chung-Hang Leung
Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China. edmondma@hkbu.edu.hk

The serendipitous discovery of the anticancer drug cisplatin cemented medicinal inorganic chemistry as an independent discipline in the 1960s. Luminescent metal complexes have subsequently been widely applied for sensing, bio-imaging, and in organic light-emitting diode applications. Transition-metal complexes possess a variety of advantages that make them suitable as therapeutics and as luminescent probes for biomolecules. It is thus highly desirable to develop new luminescent metal complexes that either interact with DNA through different binding modes or target alternative cellular machinery such as proteins as well as to provide a more effective means of monitoring disease progression. In this Review, we highlight recent examples of biologically active luminescent metal complexes that can target and probe a specific biomolecule, and offer insights into the future potential of these compounds for the investigation and treatment of human diseases.

UI MeSH Term Description Entries
D008163 Luminescent Measurements Techniques used for determining the values of photometric parameters of light resulting from LUMINESCENCE. Bioluminescence Measurements,Bioluminescent Assays,Bioluminescent Measurements,Chemiluminescence Measurements,Chemiluminescent Assays,Chemiluminescent Measurements,Chemoluminescence Measurements,Luminescence Measurements,Luminescent Assays,Luminescent Techniques,Phosphorescence Measurements,Phosphorescent Assays,Phosphorescent Measurements,Assay, Bioluminescent,Assay, Chemiluminescent,Assay, Luminescent,Assay, Phosphorescent,Assays, Bioluminescent,Assays, Chemiluminescent,Assays, Luminescent,Assays, Phosphorescent,Bioluminescence Measurement,Bioluminescent Assay,Bioluminescent Measurement,Chemiluminescence Measurement,Chemiluminescent Assay,Chemiluminescent Measurement,Chemoluminescence Measurement,Luminescence Measurement,Luminescent Assay,Luminescent Measurement,Luminescent Technique,Measurement, Bioluminescence,Measurement, Bioluminescent,Measurement, Chemiluminescence,Measurement, Chemiluminescent,Measurement, Chemoluminescence,Measurement, Luminescence,Measurement, Luminescent,Measurement, Phosphorescence,Measurement, Phosphorescent,Measurements, Bioluminescence,Measurements, Bioluminescent,Measurements, Chemiluminescence,Measurements, Chemiluminescent,Measurements, Chemoluminescence,Measurements, Luminescence,Measurements, Luminescent,Measurements, Phosphorescence,Measurements, Phosphorescent,Phosphorescence Measurement,Phosphorescent Assay,Phosphorescent Measurement,Technique, Luminescent,Techniques, Luminescent
D008670 Metals Electropositive chemical elements characterized by ductility, malleability, luster, and conductance of heat and electricity. They can replace the hydrogen of an acid and form bases with hydroxyl radicals. (Grant & Hackh's Chemical Dictionary, 5th ed) Metal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D049408 Luminescent Agents Compound such as LUMINESCENT PROTEINS that cause or emit light (PHYSICAL LUMINESCENCE). Phosphorescent Agents,Agents, Luminescent,Agents, Phosphorescent
D056831 Coordination Complexes Neutral or negatively charged ligands bonded to metal cations or neutral atoms. The number of ligand atoms to which the metal center is directly bonded is the metal cation's coordination number, and this number is always greater than the regular valence or oxidation number of the metal. A coordination complex can be negative, neutral, or positively charged. Metal Complexes,Complexes, Coordination,Complexes, Metal

Related Publications

Dik-Lung Ma, and Hong-Zhang He, and Ka-Ho Leung, and Daniel Shiu-Hin Chan, and Chung-Hang Leung
November 2021, JACS Au,
Dik-Lung Ma, and Hong-Zhang He, and Ka-Ho Leung, and Daniel Shiu-Hin Chan, and Chung-Hang Leung
October 2022, Angewandte Chemie (International ed. in English),
Dik-Lung Ma, and Hong-Zhang He, and Ka-Ho Leung, and Daniel Shiu-Hin Chan, and Chung-Hang Leung
January 2005, Topics in current chemistry,
Dik-Lung Ma, and Hong-Zhang He, and Ka-Ho Leung, and Daniel Shiu-Hin Chan, and Chung-Hang Leung
January 2020, Current medicinal chemistry,
Dik-Lung Ma, and Hong-Zhang He, and Ka-Ho Leung, and Daniel Shiu-Hin Chan, and Chung-Hang Leung
December 2011, Biophysical reviews,
Dik-Lung Ma, and Hong-Zhang He, and Ka-Ho Leung, and Daniel Shiu-Hin Chan, and Chung-Hang Leung
March 1996, Chemical reviews,
Dik-Lung Ma, and Hong-Zhang He, and Ka-Ho Leung, and Daniel Shiu-Hin Chan, and Chung-Hang Leung
August 2012, Angewandte Chemie (International ed. in English),
Dik-Lung Ma, and Hong-Zhang He, and Ka-Ho Leung, and Daniel Shiu-Hin Chan, and Chung-Hang Leung
May 2012, Dalton transactions (Cambridge, England : 2003),
Dik-Lung Ma, and Hong-Zhang He, and Ka-Ho Leung, and Daniel Shiu-Hin Chan, and Chung-Hang Leung
August 2022, Journal of the American Chemical Society,
Dik-Lung Ma, and Hong-Zhang He, and Ka-Ho Leung, and Daniel Shiu-Hin Chan, and Chung-Hang Leung
March 2013, Acta biomaterialia,
Copied contents to your clipboard!